Library of Congress subjects (96930)
R Medicine (9332)
RS Pharmacy and materia medica (231)
Number of items at this level: 231.
A
Regulation of healthcare advertisements: comparing media regulation of the pharmaceutical industry in Kuwait and the GCC.
Alkazemi, Mariam
A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness. (2018)
Anderson, Michael; Naci, Huseyin; Morrison, Deborah; Osipenko, Leeza; Mossialos, Elias
Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden.
Angelis, Aris
Why are the prices of new medicines so high and what can we do about it? (F8).
Angelis, Aris
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework.
Angelis, Aris; Kanavos, Panos
Advancing structured decision-making in drug regulation at the FDA and EMA.
Angelis, Aris; Phillips, Lawrence D.
picture_as_pdf
To switch or not to switch? Patient attitudes towards generic substitution in Greece.
Athanasakis, Kostas; Kyriopoulos, Ilias; Kyriopoulos, John
B
Book review: Wellcome & co.: knowledge, trust, profit and the transformation of the British pharmaceutical industry, 1880-1940.
Bakker, Gerben
Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Banerjee, Sube; Hellier, J; Romer, R; Dewey, M; Knapp, Martin; Ballard, C; Baldwin, Robert; Bentham, Peter; Fox, C.; Holmes, Clive; Katona, Cornelius; Livingston, G.; Lawton, C; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, J; Orrell, Martin; O'Brien, J; Poppe, M; Thomas, A; Walwyn, R; Wilson, K; Burns, A; Lindesay, James
MMR, the media and risk.
Beckett, Charlie
Linear Categorical Marginal Modeling of solicited symptoms in vaccine clinical trials.
Bergsma, W. P.; Aris, E. M. D.; Tibaldi, F. S.
Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium.
Beutels, Philippe; Luyten, Jeroen; Lejeune, Olivier; Hens, Niel; Bilcke, Joke; De Schrijver, Koen; Van de Sande, Stefaan; Van Herck, Koen; Van Damme, Pierre
Optimum design of experiments for enzyme inhibition kinetic models.
Bogacka, Barbara; Patan, Maciej; Johnson, Patrick, J; Youdim, K; Atkinson, Anthony C.
Tender Loving Care? Purchasing medicines for continuing therapeutic improvement and better health outcomes.
Bonser, Andrew; Kanavos, Panos; Taylor, David
Creative compliance in pharmaceutical markets: the case of profit controls.
Bradley, James; Vandoros, Sotiris
C
Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making.
Cerri, Karin H.; Knapp, Martin; Fernandez, Jose-Luis
Patents and the global diffusion of new drugs.
Cockburn, Iain; Lanjouw, Jean O.; Schankerman, Mark
Pharma online: does regulation or corporate social media policy need to change to allow a real dialogue about medicines?
Cohen, Lucía
Regulation as global drug governance: how new is the NPS phenomenon?
Collins, John
picture_as_pdf
Knowledge production vs knowledge management: the case of pharmaceutical R&D.
Cordella, Antonio
Distributed knowledge across boundaries.
Cordella, Antonio; Grisot, M.
The digital future beyond the pill.
Cornford, Tony
Learning lessons from electronic prescribing implementations in secondary care.
Cornford, Tony; Savage, Imogen; Jani, Yogini; Franklin, Bryony Dean; Barber, Nick; Slee, Ann; Jacklin, Ann
Deregulation and access to medicines: the Peruvian experience.
Costa-Font, Joan
Regulation effects on the adoption of new medicines.
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe
How important is patient brand loyalty in the uptake of generic drugs?
Costa-Font, Joan; Rudisill, Caroline; Stefanie, Tan
Parallel trade in medicinal drugs is putting the welfare of EU patients at risk.
Costa-i-Font, Joan
A 'Health Kuznets' curve'? Cross-country and longitudinal evidence.
Costa-i-Font, Joan; Hernandez-Quevedo, Christina; Sato, Azusa
Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008.
Costa-i-Font, Joan; Varol, Nebibe; McGuire, Alistair
The war over drugs: what’s at stake?
Coulter, Steve
Physician altruism and moral hazard:(no) evidence from Finnish national prescriptions data.
Crea, Giovanni; Galizzi, Matteo M.; Linnosmaa, Ismo; Miraldo, Marisa
picture_as_pdf
D
$1 million for a drug used once.
Dickson, Jane
165,000 and counting!
Dickson, Jane
Books about the future of medicine, digital doctors, patient safety etc.
Dickson, Jane
D3 Research presents a poster at the LSE Research Festival.
Dickson, Jane
The D3 project.
Dickson, Jane
Digital necklace wins Unicef award.
Dickson, Jane
E-prescribing and ADE in primary care – data and evidence from meaningful use in the US.
Dickson, Jane
Enduring and emerging challenges of informed consent.
Dickson, Jane
Mental health monitoring through ‘selfie’ videos and social media tracking.
Dickson, Jane
NHS England initiative: ‘combinatorial innovation’ in NHS test beds.
Dickson, Jane
National systems of patient unique identifiers – nations pro and against.
Dickson, Jane
Non-adherence to prescriptions is categorical construct. Non-persistence adds a time dimension to it.
Dickson, Jane
Personalized medicine: a podcast.
Dickson, Jane
Pharmacogenetics test lab embedded in ePrescribing, for personalised medicine?
Dickson, Jane
Precision medicine on BBC Radio 4 Today Programme.
Dickson, Jane
Research hypothesis and objectives.
Dickson, Jane
Results of latest international action on counterfeit and unlicensed medicines.
Dickson, Jane
Serialisation of individual pills to defeat counterfeiters.
Dickson, Jane
Shining a light on Lumosity’s claims.
Dickson, Jane
Sounds like a diagnosis?
Dickson, Jane
Stratified medicine in 2015 – Leeds Christmas lecture.
Dickson, Jane
Tackling the problem of sub-standard therapeutic drugs in Kenya.
Dickson, Jane
Testing & mental health apps.
Dickson, Jane
Type 1 diabetes breakthrough.
Dickson, Jane
Vita brevis ars longa: feeding Watson on dubious data.
Dickson, Jane
Vocal biomarkers: diagnostics through human voice.
Dickson, Jane
Warfarin history timeline.
Dickson, Jane
Worrying about data.
Dickson, Jane
A decision support tool for warfarin prescribing.
Dickson, Jane
How academics and service providers are working together to inform drug policy in Ireland.
Duffin, Tony
Why is doping wrong anyway?
Dyke, Heather
Patient’s perception of medication and nonadherence to chronic disease treatments. A population-based study in Brazil.
da Silva Menolli, Poliana Vieira; Brummel, Adriana Mitsue Ivama; Guidoni, Camilo Molino; Girotto, Edmarlon
picture_as_pdf
F
Learning and interest accommodation in policy and institutional change: EC risk regulation in the pharmaceuticals sector.
Feick, Jürgen
Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden.
Ferrario, Alessandra; Kanavos, Panos
picture_as_pdf
Managed entry agreements for pharmaceuticals: the European experience.
Ferrario, Alessandra; Kanavos, Panos
An in-depth analysis of pharmaceutical regulation in the Republic of Moldova.
Ferrario, Alessandra; Sautenkova, Nina; Bezverhni, Zinaida; Seicas, Rita; Habicht, Jarno; Kanavos, Panos; Safta, Vladimir
Book review:Enforcing Freedom: Drug Courts, Therapeutic Communities and the Intimacies of the State by Kerwin Kaye.
Ford, Alessandro
picture_as_pdf
Book review:Pills, powder and smoke: inside the bloody war on drugs by Antony Loewenstein.
Ford, Alessandro
picture_as_pdf
G
What the national IT programme means for pharmacy and pharmacists.
Gandecha, Reshma; Klecun, Ela; Jacklin, Ann; Williams, Simon
Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment.
Gerard, Karen; Tinelli, Michela; Latter, Sue; Blenkinsopp, Alison; Smith, Alesha
On compulsory licensing of trade secrets to safeguard public health. (2025)
Gurgula, Olga; Luke, David
picture_as_pdf
H
How the US states have learned from each other to create more comprehensive medical cannabis policies.
Hannah, A. Lee; Mallinson, Daniel J.
picture_as_pdf
Mechanisms of regulatory capture:testing claims of industry influence in the case of Vioxx.
Heims, Eva; Moxon, Sophie
picture_as_pdf
Medicare drug price negotiation:the complexities of selecting therapeutic alternatives for estimating comparative effectiveness.
Hernandez, Inmaculada; Cousin, Emma; Wouters, Olivier J.; Gabriel, Nico; Cameron, Teresa; Sullivan, Sean D.
picture_as_pdf
Accelerating access to new drugs in Japan.
Hibberd, Ralph
Brexit and the falsified medicines directive.
Hibberd, Ralph
Combating falsified medicines in Africa through digital artefacts.
Hibberd, Ralph
Hub and spoke dispensing: privacy and sociotechnical rigidity.
Hibberd, Ralph
Hub and spoke dispensing: safety and sociotechnical pliability.
Hibberd, Ralph
The evaluation of the electronic prescription service in primary care: interim report on the findings from the evaluation in early implementer sites.
Hibberd, Ralph; Barber, Nick; Cornford, Tony; Lichtner, Valentina
Measures of effectiveness in medical research:reporting both absolute and relative measures. (2021)
Hoefer, Carl; Krauss, Alexander
picture_as_pdf
Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study.
Hong, Jihyung; Reed, Catherine; Novick, Diego; Haro, Josep Maria; Aguado, Jaume
Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses.
Howard, Robert; McShane, Rupert; Lindesay, James; Ritchie, Craig; Baldwin, Ashley; Barber, Robert; Burns, Alistair; Dening, Tom; Findlay, David; Holmes, Clive; Jones, Robert; Jones, Roy; McKeith, Ian; Macharouthu, Ajay; O'Brien, John; Sheehan, Bart; Juszczak, Edmund; Katona, Cornelius; Hills, Robert; Knapp, Martin; Ballard, Clive; Brown, Richard G; Banerjee, Sube; Adams, Jessica; Johnson, Tony; Bentham, Peter; Phillips, Patrick P J
IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines.
Hughes, Diana; Waddingham, Ed, A., J.; Mt-Isa, Shahrul; Goginsky, Alesia; Chan, Edmond; Downey, Gerald; Hallgreen, Christine E.; Hockley, Kimberley S.; Juhaeri, Juhaeri; Lieftucht, Alfons; Metcalfe, Marilyn, A.; Noel, Rebecca, A.; Phillips, Lawrence D.; Ashby, Deborah; Micaleff, Alain
J
Regulatory consequences of “Brexit” for the development of medicinal products.
Jackson, Emily; Feldschreiber, P; Breckenridge, A
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Jackson, N.; Atar, D.; Borentain, M.; Breithardt, G.; van Eickels, M.; Endres, M.; Fraass, U.; Friede, T.; Hannachi, H.; Janmohamed, S.; Kreuzer, J.; Landray, M.; Lautsch, D.; Le Floch, C.; Mol, P.; Naci, H.; Samani, N. J.; Svensson, A.; Thorstensen, C.; Tijssen, J.; Vandzhura, V.; Zalewski, A.; Kirchhof, P.
The Community Pharmacy Medicines Management Project: final report.
Jaffray, Mariesha; Bond, Christine; Tinelli, Michela
The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease.
Jaffray, Mariesha; Bond, Christine M.; Watson, M. C.; Hannaford, Philip; Tinelli, Michela; Scott, A.; Lee, A.; Blenkinsopp, Alison; Anderson, Cameron; Avery, Anthony; Bissell, P.; Krksa, J.
Spain: the effect of country of birth on patterns of pharmaceutical use.
Jiménez Rubio, Dolores; Hernández-Quevedo, Cristina
K
Medical marijuana laws and mental health in the United States.
Kalbfuß, Jörg; Odermatt, Reto; Stutzer, Alois
Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. (2021)
Kamphuis, Bregtje W.; Kanavos, Panos
picture_as_pdf
Financing pharmaceuticals in transition.
Kanavos, Panos
Overview of pharmaceutical pricing and reimbursement regulation.
Kanavos, Panos
Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1?
Kanavos, Panos; Angelis, Aris
An EU-wide approach to HTA:an irrelevant development or an opportunity not to be missed?
Kanavos, Panos; Angelis, Aris; Drummond, Michael
Outstanding regulatory issues in the European Union pharmaceutical market.
Kanavos, Panos; Mossialos, Elias
What is wrong with orphan drug policies?: suggestions for ways forward.
Kanavos, Panos; Nicod, Elena
Determinants of branded prescription medicine prices in OECD countries.
Kanavos, Panos; Vandoros, Sotiris
The European pharmaceutical market and policies - outlook for the future.
Kanavos, Panos; Vandoros, Sotiris; Irwin, Rachel; Nicod, Elena; Casson, Margaret
Competition issues in the distribution of pharmaceuticals.
Kanavos, Panos; Wouters, Olivier J.
Concurrence dans la distribution de produits pharmaceutiques.
Kanavos, Panos; Wouters, Olivier J.
Pricing of in-patent pharmaceuticals in the Middle East and North Africa:is external reference pricing implemented optimally?
Kanavos, Panos; Kamphuis, Bregtje; Fontrier, Anna-Maria; Parkin, Georgia Colville; Saleh, Shadi; Akhras, Kasey S.
picture_as_pdf
The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe.
Kawalec, Paweł; Sagan, Anna; Pilc, Andrzej
Fertility history and use of antidepressant medication in late mid-life: a register-based analysis of Norwegian women and men.
Kravdal, Øystein; Grundy, Emily; Skirbekk, Vegard
L
Levels and determinants of over-prescribing of antibiotics in the public and private primary care sectors in South Africa. (2023)
Lagarde, Mylène; Blaauw, Duane
picture_as_pdf
Crisis management in community pharmacies during a pandemic. (2024)
Latonen, S.; Neuvonen, E.; Juppo, A. M.; Seeck, H.; Airaksinen, M.
picture_as_pdf
Crisis management in the pharmaceutical industry during the COVID-19 pandemic. (2025)
Latonen, S.; Pussila, S.; Seeck, H.; Airaksinen, M.; Juppo, A. M.
picture_as_pdf
Structured approaches to benefit-risk assessment: a case study and the patient perspective.
Levitan, Bennett; Phillips, Lawrence D.; Walker, Stuart
Antidepressant use in 27 European countries: associations with sociodemographic, cultural and economic factors.
Lewer, D.; O'Reilly, C.; Mojtabai, R.; Evans-Lacko, S.
‘the little liar’ – patient information about medicines.
Lichtner, Valentina
Modernising the business of health: pharmaceuticals in Britain, in comparison with Germany and the United States, 1890-1940.
Liebenau, Jonathan
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
Luciano, Juan V.; D’Amico, Francesco; Cerdà-Lafont, Marta; Peñarrubia-María, María T.; Knapp, Martin; Cuesta-Vargas, Antonio I.; Serrano-Blanco, Antoni; García-Campayo, Javier
Costing infectious disease outbreaks for economic evaluation.
Luyten, Jeroen; Beutels, Philippe
Kicking against the pricks: vaccine sceptics have a different social orientation.
Luyten, Jeroen; Desmet, Pieter; Dorgali, Veronica; Hens, Niel; Beutels, Philippe
Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study.
Luyten, Jeroen; Dorgali, Veronica; Hens, Niel; Beutels, Philippe
Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis A patients.
Luyten, Jeroen; Marais, Christiaan; Hens, Niel; De Schrijver, Koen; Beutels, Philippe
Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
Luyten, Jeroen; Van de Sande, Stefaan; De Schrijver, Koen; Van Damme, Pierre; Beutels, Philippe
Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting.
Luyten, Jeroen; Vandevelde, Antoon; Van Damme, Pierre; Beutels, Philippe
M
VP164 Applying health technology assessment to pharmacy: the Italian-Medicine-Use-Review-Health Technology Assessment.
Manfrin, Andrea; Knapp, Martin; Cicchetti, Americo; Mandelli, Andrea; Tinelli, Michela
Community pharmacists and drug misusers: national trends in attitudes and current practice.
Matheson, Catriona; Bond, C.; Tinelli, Michela
Why do some countries approve a cancer drug and others don't?
Maynou-Pujolras, Laia; Cairns, John
The association of a critical care electronic prescribing system with the quality of patient care provided by clinical pharmacists - a prospective, observational cohort study.
Mehta, Reena; Onatade, Raliat; Vlachos, Savvas; Sloss, Rhona; Maharaj, Ritesh
picture_as_pdf
Pharmaceutical patent term extension and patent prosecution in Brazil (1997-2018). (2022)
Mercadante, Eduardo; Paranhos, Julia
picture_as_pdf
IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab).
Micaleff, Alain; Callreus, Tornbjorn; Phillips, Lawrence D.; Hughes, Diana; Hockley, Kimberley; Wang, Nan; Luciani, David
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. (2022)
Michaeli, Daniel Tobias; Mills, Mackenzie; Michaeli, Thomas; Miracolo, Aurelio; Kanavos, Panos
picture_as_pdf
Using international human rights law to guarantee the right to health: a Brazilian experience.
Morais de Oliveira, Iago
From "retailers" to health care providers: transforming the role of community pharmacists in chronic disease management.
Mossialos, Elias; Courtin, Emilie; Naci, Huseyin; Benrimoj, Shalom; Bouvy, Marcel; Farris, Karen; Noyce, Peter; Sketris, Ingrid
picture_as_pdf
Building a strong pharmaceutical system for China.
Mossialos, Elias; Ge, Yanfeng; Hu, Jia; Wang, Liejun
Policy options for pharmaceutical research and development in the European Community.
Mossialos, Elias; Kanavos, Panos; Abel-Smith, B.
The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading.
Mossialos, Elias; Mrazek, Monique F.
Pharmaceutical policies in Finland - challenges and opportunities.
Mossialos, Elias; Srivastava, Divya
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Mt-Isa, Shahrul; Hallgreen, Christine E.; Wang, Nan; Callréus, Torbjörn; Genov, Georgy; Hirsch, Ian; Hobbiger, Stephen F.; Hockley, Kimberley S.; Luciani, Davide; Phillips, Lawrence D.; Quartey, George; Sarac, Sinan B.; Stoeckert, Isabelle; Tzoulaki, Ioanna; Micaleff, Alain; Ashby, Deborah
Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2.
Mt-Isa, Shahrul; Hallgreen, Christine, E.; Asiimwe, Alex; Downey, Gerry; Genov, Georgy; Hermann, Richard; Hughes, Diana; Lieftucht, Alfons; Noel, Rebecca; Peters, Ruth; Phillips, Lawrence D.; Shepherd, Susan; Micaleff, Alain; Ashby, Deborah; Tzoulak, Ioanna
Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: Stage 1 of 2.
Mt-Isa, Shahrul; Peters, Ruth; Phillips, Lawrence D.; Chan, Kakit; Hockley, Kimberley S.; Wang, Nan; Ashby, Deborah; Tzoulak, Ioanna
Medicines dispensers' knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania.
Mwita, Stanley; Jande, Mary; Marwa, Karol; Hamasaki, Kayo; Katabalo, Deogratius; Burger, Johanita; Godman, Brian; Ferrario, Alessandra; Massele, Amos; Ruganuza, Deodatus
N
Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector.
Naci, Huseyin; Carter, Alexander W.; Mossialos, Elias
picture_as_pdf
Why the drug development pipeline is not delivering better medicines.
Naci, Huseyin; Carter, Alexander W.; Mossialos, Elias
Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval.
Naci, Huseyin; Wouters, Olivier J.; Gupta, Radhika; Ioannidis, John P. A.
Specialty drugs:a distinctly American phenomenon.
Naci, Huseyin; Kesselheim, Aaron S.
picture_as_pdf
Generating comparative evidence on new drugs and devices before approval.
Naci, Huseyin; Salcher-Konrad, Maximilian; Kesselheim, Aaron S.; Dr.rer.nat, Beate Wiesler; Rochaix, Lise; Redberg, Rita; Salanti, Georgia; Jackson, Emily; Garner, Sarah; Stroup, Scott; Cipriani, Andrea
picture_as_pdf
HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries.
Nicod, Elena; Annemans, Lieven; Bucsics, Anna; Lee, Anne; Upadhyaya, Sheela; Facey, Karen
P
Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies.
Pan, Yi-Ju; Knapp, Martin; McCrone, Paul R.
The politics of the EU pharmaceutical industry.
Permanand, Govin; Altenstetter, Christa
Theorising the development of the European Union framework for pharmaceutical regulation.
Permanand, Govin; Mossialos, Elias
The Covid-19 pandemic means that the running down of US Strategic Stockpile of medicines could not have come at a worse time.
Pettus, Katherine
picture_as_pdf
Benefit-risk modeling of medicinal products: methods and applications. (2013)
Phillips, Lawrence D.
IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone.
Phillips, Lawrence D.; Amzal, Billy; Asiimwe, Alex; Chan, Edmond; Chen, Chen; Hughes, Diana; Juhaeri, Juhaeri; Micaleff, Alain; Mt-Isa, Shahrul; Noel, Becky; Shepherd, Susan; Wang, Nan
Is quantitative benefit–risk modelling of drugs desirable or possible?
Phillips, Lawrence D.; Fasolo, Barbara; Zafiropoulos, Nikolaos; Beyer, Andrea
S
A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK.
Salas-Vega, Sebastian; Bertling, Annika; Mossialos, Elias
Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US.
Salas-Vega, Sebastian; Shearer, Emily; Mossialos, Elias
picture_as_pdf
Approval of cancer drugs with uncertain therapeutic value:a comparison of regulatory decisions in Europe and the United States.
Salcher-Konrad, Maximilian; Naci, Huseyin; Davis, Courtney
picture_as_pdf
Drug patenting in India: looking back andlooking forward.
Sampat, Bhaven N.; Shadlen, Kenneth C.
Challenges to India's pharmaceutical patent laws.
Sampat, Bhaven N.; Shadlen, Kenneth C.; Amin, Tahir M.
Medical cannabis in the UK:from principle to practice.
Schlag, Anne Katrin; Baldwin, David S.; Barnes, Michael; Bazire, Steve; Coathup, Rachel; Curran, H. Valerie; McShane, Rupert; Phillips, Lawrence D.; Singh, Ilina; Nutt, David J.
picture_as_pdf
Information and diffusion of new prescription drugs.
Serra-Sastre, Victoria; McGuire, Alistair
Debating Patents and Drug Prices: Trade Agreements and the Trans-Pacific Partnership.
Shadlen, Kenneth C.
Learning from India? A new approach to secondary pharmaceutical patents.
Shadlen, Kenneth C.
picture_as_pdf
The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil.
Shadlen, Kenneth C.
The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies. (2011)
Shadlen, Kenneth C.
Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment.
Shadlen, Kenneth C.; Guennif, Samira; Guzmán, Alenka; Lalitha, N.
Drug patenting in India:looking back and looking forward.
Shadlen, Kenneth C.; Sampat, Bhaven N.
picture_as_pdf
Indian pharmaceutical patent prosecution: the changing role of Section 3(d).
Shadlen, Kenneth C.; Sampat, Bhaven N.
Balancing innovation and access: India’s pharmaceutical patent laws.
Shadlen, Kenneth C.; Sampat, Bhaven N.; Amin, Tahir M.
picture_as_pdf
Patents, trade, and medicines:past, present, and future.
Shadlen, Kenneth C.; Sampat, Bhaven N.; Kapczynski, Amy
picture_as_pdf
Association between preapproval confirmatory trial initiation and conversion to traditional approval or withdrawal in the FDA accelerated approval pathway. (2023)
Shahzad, Mahnum; Naci, Huseyin; Wagner, Anita K.
Big Pharma must embrace the shift to technological solutions in healthcare.
Shaked, Yoav
picture_as_pdf
Investing in health R&D:where we are, what limits us, and how to make progress in Africa.
Simpkin, Victoria; Namubiru-Mwaura, Evelyn; Clarke, Lorcan; Mossialos, Elias
picture_as_pdf
Application-specific R&D capabilities and the advantage of incumbents: evidence from the anticancer drug market.
Sosa, M. Lourdes
Decoupling market incumbency from organizational prehistory: locating the real sources of competitive advantage in R&D for radical innovation.
Sosa, M. Lourdes
Analysis of prices paid by low-income countries: how price sensitive is government demand for medicines?
Srivastava, Divya; McGuire, Alistair
Understanding support for complementary and alternative medicine in general populations:Use and perceived efficacy.
Stoneman, Paul; Sturgis, Patrick; Allum, Nick
The consequences of pharmaceutical tariffs in the United States. (2025)
Sullivan, Sean D.; Grueger, Jens; Sullivan, Aidan P.; Ramsey, Scott D.
Integrating price benchmarks and comparative clinical effectiveness to inform the medicare drug price negotiation program. (2024)
Sullivan, Sean D.; Wouters, Olivier J.; Cousin, Emma M.; Kirihennedige, Ayuri S.; Hernandez, Inmaculada
picture_as_pdf
T
Compulsory licenses for pharmaceuticals: an inconvenient truth?
Thambisetty, Sivaramjani
Improving access to patented medicines: are human rights getting in the way?
Thambisetty, Sivaramjani
Novartis v Union of India and the person skilled in the art: a missed opportunity.
Thambisetty, Sivaramjani
Novartis v Union of India and the person skilled in the art: a missed opportunity.
Thambisetty, Sivaramjani
Improving access to patented medicines:are human rights getting in the way?
Thambisetty, Sivaramjani
picture_as_pdf
Better outcomes for the patient, the provider and the society now: this is not a dream, and the pharmacist could help!
Tinelli, Michela
Costi dell’aterosclerosi.
Tinelli, Michela
Developing and applying discrete choice experiments (DCEs) to inform pharmacy policy.
Tinelli, Michela
Neuropatie diabetiche ed L-carnitina: nuove prospettive di trattamento.
Tinelli, Michela
Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care.
Tinelli, Michela; Blenkinsopp, Alison; Latter, Sue; Smith, Alesha; Chapman, Stephen R.
The MEDMAN project: evaluation of the medicines management training for community pharmacists.
Tinelli, Michela; Jaffray, M; Krksa, J.; Bond, Christine M.
VP164: Applying HTA to pharmacy: the Italian-Medicine-Use-Review-HTA.
Tinelli, Michela; Manfrin, Andrea; Knapp, Martin; Mandelli, A.
Economic evaluation advancement in pharmacy: discrete choice experiments (DCEs).
Tinelli, Michela; Ryan, M.; Bond, Christine
Session 1A: methods. Discrete choice experiments (DCEs) to inform pharmacy policy: going beyond Quality Adjusted Life Years (QALYs).
Tinelli, Michela; Ryan, M.; Bond, Christine
Patient-centred approach to policy development: a pharmacy-led medicines management service.
Tinelli, Michela; Ryan, Mandy; Bond, Christine
Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider.
Tinelli, Michela; White, John; Manfrin, Andrea
picture_as_pdf
V
Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union.
Vandoros, Sotiris; Kanavos, Panos
Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment?
Varol, Nebibe; Costa-i-Font, Joan; McGuire, Alistair
In Italy primary care prescriptions all electronic from 1 March 2016.
Vazza, Lucilla
Challenges and opportunities for pharmaceutical pricing and reimbursement policies.
Vogler, Sabine; Zimmermann, Nina; Ferrario, Alessandra; Wirtz, Veronika J; Babar, Zaheer-Ud-Din
The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors.
Von der Schulenburg, Fritz; Vandoros, Sotiris; Kanavos, Panos
Decision making under uncertainty:comparing regulatory and health technology assessment reviews of medicines in the United States and Europe.
Vreman, Rick A.; Naci, Huseyin; Goettsch, Wim G.; Mantel-Teeuwisse, Aukje K.; Schneeweiss, Sebastian G.; Leufkens, Hubert G.M.; Kesselheim, Aaron S.
picture_as_pdf
Ranking the harm of non-medically used prescription opioids in the UK.
van Amsterdam, Jan; Phillips, Lawrence D.; Henderson, Graeme; Bell, James; Bowden-Jones, Owen; Hammersley, Richard; Ramsey, John; Taylor, Polly; Dale-Perera, Annette; Melichar, Jan; van den Brink, Wim; Nutt, David
W
The first English histories of pharmacy - their origins and influences.
Wallis, Patrick
Cancer drug indication approvals in China and the United States:a comparison of approval times and clinical benefit, 2001–2020.
Wei, Yuxuan; Zhang, Yichen; Xu, Ziyue; Wang, Guoan; Zhou, Yue; Li, Huangqianyu; Shi, Luwen; Naci, Huseyin; Wagner, Anita K.; Guan, Xiaodong
picture_as_pdf
Long read review: drug dealer, MD: how doctors were duped, patients got hooked and why it’s so hard to stop by Anna Lembke.
Williams, Thomas Christie
The impact of alternative pricing methods for drugs in California Workers’ Compensation System: fee-schedule pricing.
Wilson, Leslie; Turkistani, Fatema A.; Huang, Wei; Tran, Dang M.; Kuo Lin, Tracy
Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
Wouters, Olivier J.; Kanavos, Panos
A comparison of generic drug prices in seven European countries: a methodological analysis.
Wouters, Olivier J.; Kanavos, Panos
Sales revenues for new therapeutic agents approved by the United States Food and Drug Administration from 1995 to 2014:a retrospective study. (2024)
Wouters, Olivier J.; Kesselheim, Aaron S.; Kuha, Jouni; Luyten, Jeroen
picture_as_pdf